Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies

Letter to the Editor

References

  1. 1.
    Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. Sixth International Radiopharmaceutical Dosimetry Symposium. Stelson AS, editor. Oak Ridge:Associated Universities; 1999. p. 705–716.Google Scholar
  2. 2.
    Sprague DR, Fujita M, Ryu YH, Liow JS, Pike VW, Innis RB. Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [(11)C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses. Nucl Med Biol 2008;35:493–500.PubMedCrossRefGoogle Scholar
  3. 3.
    Brown AK, Fujita M, Fujimura Y, Liow J-S, Stabin M, Ryu YH, et al. Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28, a PET radioligand to image inflammation. J Nucl Med 2007;48:2072–9.PubMedCrossRefGoogle Scholar
  4. 4.
    NIH RSC report: improving informed consent for research radiation studies, 10/17/2001.Google Scholar
  5. 5.
    Gatley SJ. Estimation of upper limits on human radiation absorbed doses from carbon-11-labeled compounds. J Nucl Med 1993;34:2208–15.PubMedGoogle Scholar
  6. 6.
    Parsey RV, Belanger MJ, Sullivan GM, Simpson NR, Stabin MG, Van Heertum R, et al. Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans. J Nucl Med 2005;46:614–9.PubMedGoogle Scholar
  7. 7.
    Parsey RV, Sokol LO, Bélanger MJ, Kumar JS, Simpson NR, Wang T, et al. Amyloid plaque imaging agent [C-11]-6-OH-BTA-1: biodistribution and radiation dosimetry in baboon. Nucl Med Commun 2005;26:875–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Thees S, Neumaier B, Glatting G, Deisenhofer S, von Arnim CA, Reske SN, et al. Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans. Nuklearmedizin 2007;46:175–80.PubMedGoogle Scholar
  9. 9.
    Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, et al. Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates. Nucl Med Commun 2004;25:737–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET. J Nucl Med 2004;45:1555–9.PubMedGoogle Scholar
  11. 11.
    Hines CS, Liow JS, Zanotti-Fregonara P, Hirvonen J, Morse C, Pike VW, et al. Human biodistribution and dosimetry of 11C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain. PLoS One 2011;6:e25309.PubMedCrossRefGoogle Scholar
  12. 12.
    NIMH/SNIDD tracer database initiative. http://pdsp.med.unc.edu/snidd/ Accessed 17 Mar 2011.
  13. 13.
    Terry GE, Hirvonen J, Liow JS, Seneca N, Tauscher JT, Schaus JM, et al. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography. Eur J Nucl Med Mol Imaging 2010;37:1499–506.PubMedCrossRefGoogle Scholar
  14. 14.
    Liow JS, Kreisl W, Zoghbi SS, Lazarova N, Seneca N, Gladding RL, et al. P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys. J Nucl Med 2009;50:108–15.PubMedCrossRefGoogle Scholar
  15. 15.
    Seneca N, Zoghbi SS, Liow JS, Kreisl W, Herscovitch P, Jenko K, et al. Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein. J Nucl Med 2009;50:807–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Hirvonen J, Roivainen A, Virta J, Helin S, Någren K, Rinne JO. Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation. Eur J Nucl Med Mol Imaging 2010;37:606–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Kumar A, Muzik O, Chugani D, Chakraborty P, Chugani HT. PET-derived biodistribution and dosimetry of the benzodiazepine receptor-binding radioligand (11)C-(R)-PK11195 in children and adults. J Nucl Med 2010;51:139–44.PubMedCrossRefGoogle Scholar
  18. 18.
    Herscovitch P, Schmall B, Doudet D, Carson R, Eckelman WC. Biodistribution and radiation dose estimates for [C-11]raclopride. J Nucl Med 1997;38:224P.Google Scholar
  19. 19.
    Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, et al. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET. J Nucl Med 2006;47:313–9.PubMedGoogle Scholar
  20. 20.
    Ribeiro MJ, Ricard M, Bourgeois S, Lièvre MA, Bottlaender M, Gervais P, et al. Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers. Eur J Nucl Med Mol Imaging 2005;32:952–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Graham MM, Peterson LM, Muzi M, Graham BB, Spence AM, Link JM, et al. 1-[Carbon-11]-glucose radiation dosimetry and distribution in human imaging studies. J Nucl Med 1998;39:1805–10.PubMedGoogle Scholar
  22. 22.
    Laymon CM, Mason NS, Frankle WG, Carney JP, Lopresti BJ, Litschge MY, et al. Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET. J Nucl Med 2009;50:814–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Treyer V, Streffer J, Ametamey SM, Bettio A, Bläuenstein P, Schmidt M, et al. Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers. Eur J Nucl Med Mol Imaging 2008;35:766–70.PubMedCrossRefGoogle Scholar
  24. 24.
    Thierens H, van Eijkeren M, Goethals P. Biokinetics and dosimetry for [methyl-11C]thymidine. Br J Radiol 1994;67:292–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Bullich S, Slifstein M, Passchier J, Murthy NV, Kegeles LS, Kim JH, et al. Biodistribution and radiation dosimetry of the glycine transporter-1 ligand (11)C-GSK931145 determined from primate and human whole-body PET. Mol Imaging Biol 2011;13:776–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Tolvanen T, Någren K, Yu M, Sutinen E, Havu-Aurén K, Jyrkkiö S, et al. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport. Eur J Nucl Med Mol Imaging 2006;33:1178–84.PubMedCrossRefGoogle Scholar
  27. 27.
    Liu N, Li M, Li X, Meng X, Yang G, Zhao S, et al. PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans. J Nucl Med 2009;50:303–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Virta JR, Tolvanen T, Någren K, Bruck A, Roivainen A, Rinne JO. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation. J Nucl Med 2008;49:347–53.PubMedCrossRefGoogle Scholar
  29. 29.
    Tolvanen T, Yli-Kerttula T, Ujula T, Autio A, Lehikoinen P, Minn H, et al. Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data. Eur J Nucl Med Mol Imaging 2010;37:874–83.PubMedCrossRefGoogle Scholar
  30. 30.
    Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, et al. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nucl Med Commun 2009;30:314–8.PubMedCrossRefGoogle Scholar
  31. 31.
    van der Veldt AA, Hendrikse NH, Smit EF, Mooijer MP, Rijnders AY, Gerritsen WR, et al. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients. Eur J Nucl Med Mol Imaging 2010;37:1950–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. J Nucl Med 2007;48:128–33.PubMedGoogle Scholar
  33. 33.
    Santens P, De Vos F, Thierens H, Decoo D, Slegers G, Dierckx RA, et al. Biodistribution and dosimetry of carbon-11-methoxyprogabidic acid, a possible ligand for GABA-receptors in the brain. J Nucl Med 1998;39:307–10.PubMedGoogle Scholar
  34. 34.
    Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlborn M, et al. Radiation dose estimates in humans for (11)C-acetate whole-body PET. J Nucl Med 2004;45:1233–6.PubMedGoogle Scholar
  35. 35.
    Nugent AC, Neumeister A, Drevets WC, Eckelman WC, Channing MA, Herscovitch P. Human biodistribution and dosimetry of the PET benzodiazepine receptor ligand [11C]flumazenil. J Nucl Med 2004;45(Suppl):434P.Google Scholar
  36. 36.
    Deloar HM, Fujiwara T, Nakamura T, Itoh M, Imai D, Miyake M, et al. Estimation of internal absorbed dose of L-[methyl-11C]methionine using whole-body positron emission tomography. Eur J Nucl Med 1998;25:629–33.PubMedCrossRefGoogle Scholar
  37. 37.
    O’Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, et al. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172. J Nucl Med 2009;50:309–15.PubMedCrossRefGoogle Scholar
  38. 38.
    Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, et al. Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand, (11)C-NNC 112, in humans. J Nucl Med 2006;47:100–4.PubMedGoogle Scholar
  39. 39.
    Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, et al. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers. Nucl Med Biol 2007;34:465–70.PubMedCrossRefGoogle Scholar
  40. 40.
    Marthi K, Hansen SB, Jakobsen S, Bender D, Smith SB, Smith DF. Biodistribution and radiation dosimetry of [N-methyl-11C]mirtazapine, an antidepressant affecting adrenoceptors. Appl Radiat Isot 2003;59:175–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag (outside the USA) 2011

Authors and Affiliations

  1. 1.Molecular Imaging BranchNIMH, NIHBethesdaUSA

Personalised recommendations